Serial #79360061
LIVE

Serial Number

79360061

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Aug 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79360061 Trademark

Serial Number: 79360061 • Registration: 7362247

Serial #79360061 is a trademark filed by Telix Pharmaceuticals Limited on August 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

August 29, 2022

Registration Date

April 23, 2024

Published for Opposition

February 6, 2024

Goods & Services

Chemicals for pharmaceutical use in the nature of chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical drugs for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical preparations for the treatment of cancer and diseases associated with cellular proliferation; radiopharmaceutical products, namely, radiopharmaceutical diagnostic preparations and radiopharmaceutical treatment preparations for the treatment of cancer and diseases associated with cellular proliferation; none of the aforementioned for use in the treatment, prevention or diagnosis of central nervous system diseases and disorders

Exploitation of intellectual property rights, namely, licensing of intellectual property rights; licensing of intellectual property

Provision of scientific information in the field of pharmaceuticals and clinical trials; scientific and technical analysis, namely, scientific research analysis in the field of pharmaceuticals; scientific research consultancy; scientific research; scientific research in the field of pharmacy; medical research; research and development of new products; laboratory research relating to pharmaceuticals; advisory services being product development consultation relating to immunological products

Advertising services; business advisory services relating to product development; business consultancy; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialization of goods, namely, procuring of contracts for third parties for the purchase and sale of goods

Apparatus for administering pharmaceuticals, namely, medical apparatus for introducing pharmaceutical preparations into the human body; apparatus for medical purposes, namely, injection needles and injection syringes; apparatus being medical device for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jan 22, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 1, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 9, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 23, 2024 FICS
FINAL DISPOSITION PROCESSED
Oct 23, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 24, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 23, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Feb 6, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 17, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 17, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 29, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2023 TROA
REFUSAL PROCESSED BY IB
Jun 26, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 6, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 6, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 12, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 11, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 6, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 17, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 12, 2023 REPR